Alerts will be sent to your verified email
Verify Email
TRABI
|
Transgene Biotek
|
KK Shah Hospitals
|
Nidan Labs. & Health
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-39.86 % | 4.29 % | 5.6 % |
|
5yr average Equity Multiplier
|
9.29 | 1.06 | 2.37 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 0.42 | 0.36 |
|
5yr Avg Net Profit Margin
|
-67187.68 % | 9.56 % | 4.97 % |
|
Price to Book
|
2.77 | 0.0 | 0.0 |
|
P/E
|
0.0 | 46.98 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
65.65 Days | 4.11 Days | -114.04 Days |
|
Inventory Days
|
866.48 Days | 0.0 | 2.9 Days |
|
Days Receivable
|
13.05 Days | 4.11 Days | 49.45 Days |
|
Days Payable
|
1913.74 Days | 0.0 | 131.43 Days |
|
5yr Average Interest Coverage Ratio
|
-24.4 | 453.35 | 1.78 |
|
5yr Avg ROCE
|
-5.18 % | 5.37 % | 12.53 % |
|
5yr Avg Operating Profit Margin
|
-5270.55 % | 13.01 % | 33.14 % |
|
5 yr average Debt to Equity
|
0.8 | 0.0 | 1.32 |
|
5yr CAGR Net Profit
|
-42.99 % | 22.63 % | n/a |
|
5yr Average Return on Assets
|
-4.99 % | 4.04 % | 1.84 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
23.64 % | 71.36 % | 57.04 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -14.18 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Transgene Biotek
|
KK Shah Hospitals
|
Nidan Labs. & Health
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|